Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-03 Sale | 2024-04-05 8:00 pm | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 15,630 | $6.169 | $96,421 | 33,921 (Direct) | View |
| 2023-08-23 Sale | 2023-08-23 9:15 pm | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 37,062 | $4.752 | $176,119 | 46,120 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 8:00 pm | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 9,729 | $4.04 | $39,305 | 352,451 (Direct) | View |
| 2022-05-05 Sale | 2022-05-06 7:10 pm | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 5,021 | $1.72 | $8,636 | 84,567 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:20 pm | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 9,204 | $2.31 | $21,261 | 74,588 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:09 pm | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 1,722 | $10.57 | $18,202 | 119,862 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-05 Option Award | 2024-02-07 7:05 pm | N/A 2034-02-05 | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 371,500 | $0 | 371,500 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 8:00 pm | N/A 2033-02-17 | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 272,700 | $0 | 352,451 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 9:20 pm | N/A 2032-07-25 | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-05-04 Option Award | 2022-05-06 7:10 pm | N/A N/A | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 15,000 | $0 | 84,567 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 9:19 pm | N/A 2032-01-01 | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2021-03-24 Exercise | 2021-03-24 7:45 pm | N/A N/A | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 10,930 | $2.48 | 105,792 (Direct) | View |
| 2021-03-24 Exercise | 2021-03-24 7:45 pm | N/A 2025-03-10 | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 10,930 | $0 | 105,792 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-18 7:09 pm | N/A 2031-02-01 | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 50,000 | $0 | 119,862 (Direct) | View |
Ownership | 2020-12-11 6:05 pm | N/A N/A | Wave Life Sciences Ltd. | WVE | Moran Kyle Chief Financial Officer | 0 | $0 | 128,661 (Direct) | View |